How did BOLT's revenue trends shift in Q4 2024?

Bolt Biotherapeutics Inc.'s revenue trends in Q4 2024 were marked by a significant decline compared to the previous quarter and the same period in the prior year.

1. **Comparison to the Previous Quarter (Q3 2024)**:
- Revenue in Q4 2024 was $0, which is a substantial decrease from the $1.14 million reported in Q3 2024.
- This decline of 100% in revenue indicates a severe contraction in the company's sales and operational performance.

|code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code|
|---|---|---|---|---|---|---|
|BOLT|BOLT.O|Bolt Biotherapeutics|2023 Q4|48.05102763997165|2089000|186|
|BOLT|BOLT.O|Bolt Biotherapeutics|2024 Q1|188.82803943044908|5274000|186|
|BOLT|BOLT.O|Bolt Biotherapeutics|2024 Q2|-11.025819958129798|1275000|186|
|BOLT|BOLT.O|Bolt Biotherapeutics|2024 Q3|-54.86550632911392|1141000|186|

2. **Comparison to the Same Period in the Previous Year (Q4 2023)**:
- In Q4 2023, Bolt reported a revenue of $2.53 million.
- The comparison suggests a more than 80% decrease in revenue from one year to the next, which is a stark indicator of deteriorating financial health.
3. **Analysts' Expectations**:
- Analysts had expected revenue to be $790,000 for Q4 2024.
- This expectation was far from the actual revenue of $0, indicating a significant underperformance by the company relative to professional forecasts.
4. **Trends and Challenges**:
- Bolt has been facing challenges, including a decline in collaboration revenue from $2.5 million in Q3 2023 to $1.1 million in Q3 2024.
- The company's loss from operations was $16.4 million in Q3 2024, compared to $18.2 million in the same period of the previous year.
- Net loss was $15.2 million in Q3 2024, improved slightly from $16.3 million in Q3 2023.

In summary, Bolt Biotherapeutics Inc.'s revenue in Q4 2024 plummeted to $0, missing analysts' expectations and reflecting a severe downturn in the company's financial performance compared to the immediate previous quarter and the same period in the prior year.